Lung cancer screening: the way forward
Open Access
- 29 July 2008
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (4) , 557-562
- https://doi.org/10.1038/sj.bjc.6604509
Abstract
To take lung cancer screening into national programmes, we first have to answer the question whether low-dose computed tomography (LDCT) screening and treatment of early lesions will decrease lung cancer mortality compared with a control group, to accurately estimate the balance of benefits and harms, and to determine the cost-effectiveness of the intervention.Keywords
This publication has 51 references indexed in Scilit:
- Could CT screening for lung cancer ever be cost effective in the United Kingdom ?Cost Effectiveness and Resource Allocation, 2008
- The LLP risk model: an individual risk prediction model for lung cancerBritish Journal of Cancer, 2007
- A Risk Model for Prediction of Lung CancerJNCI Journal of the National Cancer Institute, 2007
- Computed Tomography Screening and Lung Cancer OutcomesPublished by American Medical Association (AMA) ,2007
- Computed tomography screening for lung cancerBMJ, 2007
- Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literatureThorax, 2007
- Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)International Journal of Cancer, 2006
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningNew England Journal of Medicine, 2006
- Lung cancer risk prediction: A tool for early detectionInternational Journal of Cancer, 2006
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999